In our studied samples of micro-tumors, we have not found alteration in MEN1, but gain status in IRS2, FOXL2 and CEBPA genes was found, suggesting that they can play a role in the development of micro- to macro-tumors, to wit insulinomas, and, accordingly, insulinomatosis. This evidence concerns the gene MEN1 and pancreatic insulinoma.